DOI: 10.7504/nk2016110301
Research progress of dose reduction or discontinuation of tumor necrosis factor inhibitors in the treatment of rheumatoid arthritis and spondyloarthritis
GUO Xu-qin
HUANG Zhi-xiang
LI Tian-wang
Keywords：tumor necrosis factor inhibitorsdose reductiondiscontinuationrheumatoid arthritisspondyloarthritis
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)